Paper3315282
Treatment of acute leukemia and malignant lymphoma with (2"R)-4'-O-tetrahydropyranyladriamycin.
Ohno R and 9 others. Cancer Chemother Pharmacol, 1987. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Treatment of acute leukemia and malignant lymphoma with (2"R)-4'-O-tetrahydropyranyladriamycin. Papers, record 3315282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3315282
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Doxorubicin | Major topic |
| Leukemia, Lymphoid | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Lymphoma | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Antibiotics, Antineoplastic | |
| Clinical Trials as Topic | |
| Drug Administration Schedule | |
| Electrocardiography | |
| Female | |
| Heart | |
| Hodgkin Disease | |
| Humans | |
| Lymphoma, Non-Hodgkin | |
| Male | |
| Middle Aged | |
| Naphthacenes |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3963850 | [Phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with solid tumors. Multi-Institutional Cooperative Study]. | Gan To Kagaku Ryoho | 1986 | https://conductscience.org/library/papers/3963850 | PubMed |
| 2 | 6526737 | Cellular uptake and efflux and cytostatic activity of 4'-O-tetrahydropyranyladriamycin in adriamycin-sensitive and resistant tumor cell lines. | J Antibiot (Tokyo) | 1984 | https://conductscience.org/library/papers/6526737 | PubMed |
| 3 | 6882000 | [Preliminary phase II clinical study of 4'-O-tetrahydropyranyl doxorubicin (THP-ADM)]. | Gan To Kagaku Ryoho | 1983 | https://conductscience.org/library/papers/6882000 | PubMed |
| 4 | 3947106 | [Comparative studies on the pharmacokinetics between THP and adriamycin in the same patients]. | Gan To Kagaku Ryoho | 1986 | https://conductscience.org/library/papers/3947106 | PubMed |
| 5 | 7363403 | The clinical evaluation of analogs--III. Anthracyclines. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/7363403 | PubMed |
| 6 | 4179349 | Daunorubicin in the treatment of acute myelocytic leukaemia. | Lancet | 1969 | https://conductscience.org/library/papers/4179349 | PubMed |
| 7 | 373923 | Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopecia. | Cancer Chemother Pharmacol | 1978 | https://conductscience.org/library/papers/373923 | PubMed |
| 8 | 3966806 | [Phase I trial of 4'-O-tetrahydropyranyl-doxorubicin (THP)--a multi-institutional cooperative study]. | Gan To Kagaku Ryoho | 1985 | https://conductscience.org/library/papers/3966806 | PubMed |
| 9 | 3861002 | THP-ADM in the treatment of acute promyelocytic leukemia. | Tohoku J Exp Med | 1985 | https://conductscience.org/library/papers/3861002 | PubMed |
| 10 | 5243015 | Rubidomycin in acute leukaemia in adults. | Br Med J | 1968 | https://conductscience.org/library/papers/5243015 | PubMed |
| 11 | 6833151 | Rapid uptake by cultured tumor cells and intracellular behavior of 4'-O-tetrahydropyranyladriamycin. | J Antibiot (Tokyo) | 1983 | https://conductscience.org/library/papers/6833151 | PubMed |
| 12 | 5474180 | Phase I and preliminary phase II evaluation of adriamycin (NSC 123127). | Cancer Res | 1970 | https://conductscience.org/library/papers/5474180 | PubMed |
| 13 | 3954376 | [Pharmacokinetic studies of THP-ADM (tetrahydropyranyl adriamycin)]. | Gan To Kagaku Ryoho | 1986 | https://conductscience.org/library/papers/3954376 | PubMed |
| 14 | 1107570 | Adriamycin-a review. | J Natl Cancer Inst | 1975 | https://conductscience.org/library/papers/1107570 | PubMed |
| 15 | 7459811 | Reporting results of cancer treatment. | Cancer | 1981 | https://conductscience.org/library/papers/7459811 | PubMed |
| 16 | 4290058 | Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia. | Cancer | 1967 | https://conductscience.org/library/papers/4290058 | PubMed |
| 17 | 528373 | Tetrahydropyranyl derivatives of daunomycin and adriamycin. | J Antibiot (Tokyo) | 1979 | https://conductscience.org/library/papers/528373 | PubMed |
| 18 | 5278102 | Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia. | Cancer Res | 1971 | https://conductscience.org/library/papers/5278102 | PubMed |
| 19 | 528374 | Low heart and skin toxicity of a tetrahydropyranyl derivative of adriamycin (THP-ADM) as observed by electron and light microscopy. | J Antibiot (Tokyo) | 1979 | https://conductscience.org/library/papers/528374 | PubMed |
| 20 | 3947112 | [A phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in patients with hematological malignancies. THP Study Group]. | Gan To Kagaku Ryoho | 1986 | https://conductscience.org/library/papers/3947112 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 8725039 | Radiofrequency capacitive hyperthermia combined with irradiation or chemotherapy for patients with invasive bladder cancers. | Int Urol Nephrol | 1995 | https://conductscience.org/library/papers/8725039 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3315282
GET https://conductscience.org/api/papers/v1/3315282/references?page=2